The SR-B1 Receptor as a Potential Target for Treating Glioblastoma

Figure 4

Comparison of the tendency for migration/invasion between GBM cell lines LN229 (a) and U87 (b) with differing SR-B1 expression. Statistically significant (p<0.05). No significant difference was found among different groups for U87 cell line.

(a)

(b)